Trait centric view

1. Trait name:	Subcutaneous fat thickness
   Ontology terms:	VT:1000135

   84 genes are associated with this trait, with QTL/association found

   • ACOX1: Acyl-CoA oxidase 1, palmitoyl
     evidenced by: QTL:19819; QTL:19821;
   • ADIPOQ: Adiponectin, C1Q and collagen domain containing
     evidenced by: QTL:12134; QTL:12136; QTL:12138; QTL:12140; QTL:66281;
   • ADRB1: Adrenoceptor beta 1
     evidenced by: QTL:147157;
   • ADRB2: Adrenoceptor beta 2
     evidenced by: QTL:147159;
   • ANO6: Anoctamin 6
     evidenced by: QTL:157058;
   • CACNA2D1: Calcium channel, voltage-dependent, alpha 2/delta subunit 1
     evidenced by: QTL:12993; QTL:13059;
   • CAPN1: Calpain 1, (mu/I) large subunit
     evidenced by: QTL:20729; QTL:20733;
   • CAST: Calpastatin
     evidenced by: QTL:153982; QTL:153985; QTL:153987; QTL:20752;
   • CDH12: Cadherin 12, type 2 (N-cadherin 2)
     evidenced by: QTL:25137;
   • CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha
     evidenced by: QTL:19824;
   • CIDEC: Cell death-inducing DFFA-like effector c
     evidenced by: QTL:65384; QTL:65389;
   • CRH: Corticotropin releasing hormone
     evidenced by: QTL:6038; QTL:6039; QTL:6040;
   • DECR1: 2,4-dienoyl-CoA reductase 1
     evidenced by: QTL:125822; QTL:125823; QTL:125824; QTL:125825; QTL:125826; QTL:125827;
   • DGAT1: Diacylglycerol O-acyltransferase 1
     evidenced by: QTL:20720; QTL:20721; QTL:20754; QTL:20755; QTL:31027;
   • DLK2: Delta-like 2 homolog (Drosophila)
     evidenced by: QTL:31571; QTL:31572; QTL:31573;
   • DNMT3B: DNA (cytosine-5-)-methyltransferase 3 beta
     evidenced by: QTL:30910; QTL:37584; QTL:37585; QTL:37587;
   • ELMOD1: ELMO/CED-12 domain containing 1
     evidenced by: QTL:154003;
   • EPS15L1: Epidermal growth factor receptor pathway substrate 15 like 1
     evidenced by: QTL:215029;
   • FABP4: Fatty acid binding protein 4, adipocyte
     evidenced by: QTL:124159; QTL:124161;
   • FAM184A: Family with sequence similarity 184, member A
     evidenced by: QTL:25133;
   • FASN: Fatty acid synthase
     evidenced by: QTL:18940; QTL:18948; QTL:18962; QTL:18976;
   • GALNT13: UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)
     evidenced by: QTL:154062; QTL:25127;
   • GDF11: Growth differentiation factor 11
     evidenced by: QTL:277285; QTL:277287;
   • GH1: Growth hormone 1
     evidenced by: QTL:14063; QTL:14064;
   • GHR: Growth hormone receptor
     evidenced by: QTL:11662; QTL:20540; QTL:20542;
   • HMCN1: Hemicentin 1
     evidenced by: QTL:154004; QTL:25135;
   • IFNAR1: Interferon (alpha, beta and omega) receptor 1
     evidenced by: QTL:1317;
   • IGF1: Insulin-like growth factor 1 (somatomedin C)
     evidenced by: QTL:11483; QTL:11484;
   • IGF2: Insulin-like growth factor 2 (somatomedin A)
     evidenced by: QTL:18456;
   • ITGA9: Integrin subunit alpha 9
     evidenced by: QTL:169083;
   • LCORL: Ligand dependent nuclear receptor corepressor-like
     evidenced by: QTL:20123; QTL:20126; QTL:20129;
   • LEP: Leptin
     evidenced by: QTL:11705; QTL:20701; QTL:20748; QTL:20749; QTL:30810; QTL:32192;
   • LEPR: Leptin receptor
     evidenced by: QTL:13158;
   • LPL: Lipoprotein lipase
     evidenced by: QTL:120281;
   • MAPK15: Mitogen-activated protein kinase 15
     evidenced by: QTL:153996;
   • MC4R: Melanocortin 4 receptor
     evidenced by: QTL:13220; QTL:14125; QTL:18832; QTL:18833; QTL:18834;
   • MDGA1: MAM domain containing glycosylphosphatidylinositol anchor 1
     evidenced by: QTL:157100;
   • MFSD1: Major facilitator superfamily domain containing 1
     evidenced by: QTL:56166;
   • MSTN: Myostatin
     evidenced by: QTL:11682; QTL:11684; QTL:11685; QTL:11689; QTL:11690; QTL:11691;
   • MTNR1A: Melatonin receptor 1A
     evidenced by: QTL:56974; QTL:56977; QTL:56980;
   • MYF5: Myogenic factor 5
     evidenced by: QTL:20001;
   • NAV2: Neuron navigator 2
     evidenced by: QTL:56755; QTL:56768; QTL:56769; QTL:56770; QTL:56771;
   • NCAPG: Non-SMC condensin I complex, subunit G
     evidenced by: QTL:10432; QTL:20102; QTL:20105; QTL:20108; QTL:20111; QTL:20114; QTL:20117; QTL:20120;
   • NTM: Neurotrimin
     evidenced by: QTL:157106;
   • OLR1: Oxidized low density lipoprotein (lectin-like) receptor 1
     evidenced by: QTL:170576;
   • OSBPL3: Oxysterol binding protein-like 3
     evidenced by: QTL:56147;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:15923; QTL:18427;
   • PKD2: Polycystic kidney disease 2 (autosomal dominant)
     evidenced by: QTL:153974;
   • PLS1: Plastin 1
     evidenced by: QTL:157056;
   • POMC: Proopiomelanocortin
     evidenced by: QTL:31010; QTL:31011; QTL:31012;
   • PPARG: Peroxisome proliferator-activated receptor gamma
     evidenced by: QTL:14113; QTL:30807;
   • PPM1K: Protein phosphatase, Mg2+/Mn2+ dependent 1K
     evidenced by: QTL:153968;
   • PRKDC: Protein kinase, DNA-activated, catalytic polypeptide
     evidenced by: QTL:19962; QTL:19967; QTL:19969; QTL:19970; QTL:19971;
   • PRLR: Prolactin receptor
     evidenced by: QTL:20735; QTL:20736;
   • PRNP: Prion protein
     evidenced by: QTL:1318; QTL:1393;
   • PTPRA: Protein tyrosine phosphatase, receptor type, A
     evidenced by: QTL:157067; QTL:56751;
   • RARRES1: Retinoic acid receptor responder (tazarotene induced) 1
     evidenced by: QTL:56167; QTL:56168;
   • RARRES2: Retinoic acid receptor responder (tazarotene induced) 2
     evidenced by: QTL:20678;
   • RB1CC1: RB1 inducible coiled-coil 1
     evidenced by: QTL:154001;
   • RBMS3: RNA binding motif single stranded interacting protein 3
     evidenced by: QTL:157098;
   • RORC: RAR-related orphan receptor C
     evidenced by: QTL:10067; QTL:10068; QTL:10069; QTL:10070;
   • RRP1B: Ribosomal RNA processing 1B
     evidenced by: QTL:154061;
   • RXRA: Retinoid X receptor, alpha
     evidenced by: QTL:95889;
   • SCD: Stearoyl-CoA desaturase (delta-9-desaturase)
     evidenced by: QTL:301157; QTL:301165; QTL:301172; QTL:301180;
   • SEMA5A: Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
     evidenced by: QTL:56192;
   • SLC23A3: Solute carrier family 23 member 3
     evidenced by: QTL:286272;
   • SMARCAL1: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
     evidenced by: QTL:154063;
   • SMIM19: Small integral membrane protein 19
     evidenced by: QTL:154066;
   • SMYD3: SET and MYND domain containing 3
     evidenced by: QTL:157073;
   • SPA17: Sperm autoantigenic protein 17
     evidenced by: QTL:56773;
   • ST18: ST18, C2H2C-type zinc finger
     evidenced by: QTL:157068;
   • STAT3: Signal transducer and activator of transcription 3 (acute-phase response factor)
     evidenced by: QTL:62137; QTL:62140; QTL:62145; QTL:62147;
   • STAT6: Signal transducer and activator of transcription 6, interleukin-4 induced
     evidenced by: QTL:11475; QTL:20546; QTL:20550; QTL:20551; QTL:20554;
   • SUDS3: Suppressor of defective silencing 3 homolog (S. cerevisiae)
     evidenced by: QTL:56155;
   • SYN3: Synapsin III
     evidenced by: QTL:157059;
   • TACC2: Transforming acidic coiled-coil containing protein 2
     evidenced by: QTL:157103;
   • UCP1: Uncoupling protein 1 (mitochondrial, proton carrier)
     evidenced by: QTL:13156;
   • UGT3A1: UDP glycosyltransferase 3 family, polypeptide A1
     evidenced by: QTL:154065;
   • UQCRC1: Ubiquinol-cytochrome c reductase core protein I
     evidenced by: QTL:14142; QTL:14143;
   • VEPH1: Ventricular zone expressed PH domain-containing 1
     evidenced by: QTL:56169; QTL:56170; QTL:56171;
   • VPS16: Vacuolar protein sorting 16 homolog (S. cerevisiae)
     evidenced by: QTL:56752;
   • XKR4: XK, Kell blood group complex subunit-related family, member 4
     evidenced by: QTL:20874; QTL:20875; QTL:20876;
   • ZDHHC17: Zinc finger DHHC-type containing 17
     evidenced by: QTL:157057;
   • ZFAND2B: Zinc finger AN1-type containing 2B
     evidenced by: QTL:286271;
   602 correlations are found involving Subcutaneous fat thickness